Premium
No increased risk of malformations in infants exposed to quetiapine in utero
Publication year - 2018
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30377
Subject(s) - quetiapine , in utero , medicine , congenital malformations , pregnancy , pediatrics , obstetrics , fetus , psychiatry , schizophrenia (object oriented programming) , biology , genetics
A study based on data from a reproductive safety database has found no increased risk of major malformations in infants exposed to quetiapine during early pregnancy, compared with unexposed infants whose mothers had a psychiatric illness history. These results are consistent with previous findings suggesting no strong association between fetal exposure to atypical antipsychotics and increases in the prevalence of major malformations.